Cardinal Health, Inc.
CAHCardinal Health, Inc. is a global, integrated healthcare company specializing in the distribution of pharmaceuticals and medical products. Founded in 1971 and headquartered in Dublin, Ohio, it provides supply chain services, logistics, and automation solutions to hospitals, pharmacies, and healthcare providers to improve patient care and reduce healthcare costs.
Dividend History
Investors can expect a dividend payout of $0.51 per share, scheduled to be distributed in 38 days on January 15, 2026
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| January 15, 2026 | $0.51 | 2026-01-02 | 2026-01-02 |
| October 15, 2025 | $0.51 | 2025-10-01 | 2025-10-01 |
| July 15, 2025 | $0.51 | 2025-07-01 | 2025-07-01 |
| April 15, 2025 | $0.51 | 2025-04-01 | 2025-04-01 |
| January 15, 2025 | $0.51 | 2025-01-02 | 2025-01-02 |
Dividends Summary
- Cardinal Health, Inc. has issued 89 dividend payments over the past 22 years
- The most recent dividend was paid 54 days ago, on October 15, 2025
- The highest dividend payed out to investors during this period was $0.51 per share
- The average dividend paid during this period was $0.32 per share.
Company News
The article highlights three dividend stocks with strong potential: Cardinal Health, Chevron, and Target. Each company offers unique dividend growth opportunities based on their financial performance, transformation strategies, and commitment to shareholder returns.
Cardinal Health Foundation and NAFC awarded $1.6 million in Equity Rx grants to nine charitable clinics and pharmacies across seven states to improve prescription medication access for uninsured and underinsured patients.
Cardinal Health announced its Board of Directors approved a quarterly dividend of $0.5107 per share, payable on October 15, 2025 to shareholders of record as of October 1, 2025.
Cardinal Health has recalled plastic syringes made by Jiangsu Shenli Medical Production Co. Ltd and Jiangsu Caina after the FDA found multiple quality system violations at their facilities, leading to warning letters and import alerts. The recall highlights the widespread impact of these deficiencies on patient safety.
